Cynapsus Therapeutics
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
828 Richmond St W, Toronto, Ontario, M6J...Phone Number
(416) 703-2449Website
www.cynapsus.caRevenue
$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Cynapsus Therapeutics
Cynapsus Therapeutics Inc. is a specialty pharmaceutical company focused on the central nervous system, specifically developing a fast-acting sublingual thin film for managing OFF episodes in Parkinson's disease. The company aims to provide an easy-to-use treatment option for patients suffering from debilitating symptoms associated with Parkinson's disease. Their product pipeline includes clinical trials and published data related to their innovative treatment. Cynapsus targets individuals affected by Parkinson's disease and seeks to enhance their quality of life through effective symptom management.Explore more
Cynapsus Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cynapsus Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Cynapsus Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Cynapsus Therapeutics launches new products
Click to see if Cynapsus Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Cynapsus Therapeutics recently announced quarterly report
Check out if Cynapsus Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Cynapsus Therapeutics
Funding: Get notified immidiatlly once Cynapsus Therapeutics has new funding data
Check if Cynapsus Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Cynapsus Therapeutics
Compare insights from companies similar to Cynapsus Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cynapsus Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cynapsus Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cynapsus Therapeutics.
Cynapsus Therapeutics financials insights
Gather financial insights about Cynapsus Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Private Equity
$939K
2013
Private Equity
$3.9M
Private Equity
$4.1M
2014
Private Equity
$14.5M
2015
Private Equity
$16.8M
Stock Offering
$72.5M
Cynapsus Therapeutics Tech Stack
A closer look at the technologies used by Cynapsus Therapeutics
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Cynapsus Therapeutics
Sign Up For FreeTo access detailed company insights
Cynapsus Therapeutics Inc. is a specialty pharmaceutical company focused on the central nervous system, specifically developing a fast-acting sublingual thin film for managing OFF episodes in Parkinson's disease. The company aims to provide an easy-to-use treatment option for patients suffering from debilitating symptoms associated with Parkinson's... Read More
